Skip to content
Biodatica
Start free

Investigator

Valentin Cracan

SCINTILLON INSTITUTE FOR PHOTOBIOLOGY · funded by NCI, NIA, NIGMS

Companies
2

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$1.6M

Summed across those awards.

First award
Jul 1, 2021

Latest Jun 1, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Expanding the xenotopic toolbox for compartment-specific manipulation of redox stress in cancer

    $480k

    Jun 1, 2026NCISCINTILLON INSTITUTE FOR PHOTOBIOLOGYNIH RePORTER · 11354493 (opens the source filing in a new tab)

  2. R21

    Using a xenotopic approach to manipulate redox metabolism in a tissue- and compartment-specific manner to study aging

    $501k

    May 1, 2026NIASCINTILLON INSTITUTE FOR PHOTOBIOLOGYNIH RePORTER · 11357281 (opens the source filing in a new tab)

  3. R03

    Deciphering the dichotomy of oxygen metabolism in renal cancer using a novel genetically encoded oxygen biosensor

    $96k

    Mar 1, 2024NCISCINTILLON INSTITUTE FOR PHOTOBIOLOGYNIH RePORTER · 11036270 (opens the source filing in a new tab)

  4. R35

    Expanding the set of genetically encoded tools for compartment-specific manipulation of redox metabolism in living cells

    $480k

    Jul 1, 2021NIGMSSCINTILLON INSTITUTE FOR PHOTOBIOLOGYNIH RePORTER · 11115827 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources